ADAMTS5, in particular, is a secreted protease targeting proteoglycans that has demonstrated divergent roles across cancer types—protective in human hepatocellular carcinoma, melanoma, and cancers of the digestive apparatus [7], yet associated with poor prognosis in ovarian cancer [8]. This evidence concerns the gene ADAMTS5 and ovarian carcinoma.